XML 109 R95.htm IDEA: XBRL DOCUMENT v3.25.1
Parent Company Only Condensed Financial Information, Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities [Abstract]    
Net income $ 1,926 $ 4,514
Adjustments to reconcile net loss to net cash used in operating activities [Abstract]    
Change in other assets 1,412 (677)
Change in accrued expenses and other liabilities (3,084) 2,287
Net cash provided by operating activities 1,393 7,594
Cash flows from investing activities [Abstract]    
Net cash provided by (used in) investing activities 28,223 (100,044)
Cash flows from financing activities [Abstract]    
Share repurchase - FDIC 0 (1,781)
Increase in unreleased ESOP shares 0 (3,400)
Net cash (used in) provided by financing activities (73,446) 181,540
Net change in cash and cash equivalents (43,830) 89,090
Cash and cash equivalents at beginning of the period 105,195 16,105
Cash and cash equivalents at end of the period 61,365 105,195
Broadway Financial Corporation [Member]    
Cash flows from operating activities [Abstract]    
Net income 1,926 4,514
Adjustments to reconcile net loss to net cash used in operating activities [Abstract]    
Equity in undistributed subsidiary loss income (2,422) (5,149)
Stock award expenses 593 396
Change in other assets (2,927) (1,618)
Change in accrued expenses and other liabilities (290) 152
Net cash provided by operating activities (3,120) (1,705)
Cash flows from investing activities [Abstract]    
Capital distribution to bank subsidiary 0 0
Net cash provided by (used in) investing activities 0 0
Cash flows from financing activities [Abstract]    
Share repurchase - FDIC 0 (1,781)
Dividends declared and paid - ECIP (1,567) 0
Increase in unreleased ESOP shares 0 (3,400)
Proceeds from repayment of ESOP loan 402 328
Net cash (used in) provided by financing activities (1,165) (4,853)
Net change in cash and cash equivalents (4,285) (6,558)
Cash and cash equivalents at beginning of the period 77,457 84,015
Cash and cash equivalents at end of the period $ 73,172 $ 77,457